GGrantIndex
← Leaderboards

Cory Michael Robinson

University Of Pittsburgh At Pittsburgh

$4,487,425
Attributed
$6,144,024
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,144,024 · 7

By mechanism

R01$4,616,937 · 2
R00$718,475 · 1
R21$331,862 · 1
R03$296,750 · 2
K99$180,000 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Immune Response

Research focus

Immune ResponseMacrophageInfectionBacteriaCellsMolecularMediatingImmunityInflammationCytokinePredispositionProductionSignal TransductionImmuneInterleukinsCell TypeExhibitsImmune SystemResponseMouse ModelPathway InteractionsLaboratoriesMicrobialTissues

Grant awards (21)

Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$544,872
R01 · FY2025 · AI
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$456,427
R01 · FY2025 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$539,481
R01 · FY2024 · AI
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$456,427
R01 · FY2024 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$603,802
R01 · FY2023 · AI
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$464,027
R01 · FY2023 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$547,847
R01 · FY2022 · AI
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$494,427
R01 · FY2022 · AI · contact PI
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$509,627
R01 · FY2021 · AI · contact PI
The regulation of early life interleukin-27 expression and metabolic impact$76,000
R03 · FY2021 · AI · contact PI
The regulation of early life interleukin-27 expression and metabolic impact$76,000
R03 · FY2020 · AI · contact PI
Linking macrophages to gut microbiota in obesity-enhanced colon cancer$146,834
R21 · FY2017 · CA
Linking macrophages to gut microbiota in obesity-enhanced colon cancer$185,028
R21 · FY2016 · CA
Cellular expression and regulation of interleukin-27 in the neonatal immune syste$71,500
R03 · FY2015 · AI · contact PI
Cellular expression and regulation of interleukin-27 in the neonatal immune syste$71,500
R03 · FY2014 · AI · contact PI
Cellular expression and regulation of interleukin-27 in the neonatal immune syste$1,750
R03 · FY2014 · AI · contact PI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis$226,695
R00 · FY2013 · HL · contact PI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis$242,780
R00 · FY2012 · HL · contact PI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis$249,000
R00 · FY2011 · HL · contact PI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis$90,000
K99 · FY2010 · HL · contact PI
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis$90,000
K99 · FY2009 · HL · contact PI